Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Researchers Find Zika Virus Inhibitor

By Kenny Walter | May 16, 2017

Researchers from the Sanford-Burnham Preby’s Medical Discovery Institute (SBP) in San Diego have pinpointed the molecule that inhibits the Zika virus, a step towards finding a drug to combat the virus, which has become a global epidemic.

“We identified a small molecule that inhibits the Zika virus protease and show that it blocks viral propagation in human cells and in mice,” Alexey Terskikh, Ph.D., associate professor at SBP, said in a statement. “Anti-Zika drugs are desperately needed.

“The fact that the compound seems to work in vivo is really promising, so we plan to use it as a starting point to make an even more potent and effective drug.”

The researchers used a library of compounds that co-author Alex Strongin, Ph.D., professor at SBP, that had previously shown to inhibit the same compound as the West Nile virus. They also tested other structurally similar molecules available at the SBP’s Conrad Prebys Center for Chemical Genomics to determine whether any also blocked the protease.

They were able to identify three promising compounds that were tested for their ability to prevent Zika infection of human brain cells, with the best one also showing the ability to reduce the amount of virus circulating in the blood of Zika-infected mice.

“The inhibitor’s efficacy in animals is the key to the study’s significance,” Terskikh said. “This, and the fact that the compound is likely to be safe make it especially promising.

“The compound blocks a part of the protease that’s unique to viruses, so it doesn’t inhibit similar human proteases. It’s also much more potent than previously identified inhibitors of the Zika protease.”

Zika is a significant emergent threat to global health, particularly during pregnancy. While it is not life-threatening, Zika has severe health implications beyond microcephaly—a condition where an infant’s head is significantly smaller than what is expected.

“Microcephaly is likely just the tip of the iceberg in terms of the potential adverse effects of maternal Zika infection,” Terskikh said. “There may be other, less obvious impacts on brain development that wouldn’t be apparent until later. That’s something we’re also investigating.”

Zika despite not being lethal, Zika is considered a global threat because it is spreading rapidly through the Americas, including through parts of the U.S.

The researchers are also moving forward with an experimental vaccine that is set to move into phase 2 clinical trials in June.

“In addition to a Zika vaccine, we still need antivirals,” Terskikh said. “Some people may be exposed who haven’t been vaccinated.

“Having a way to treat the infection could help stop Zika from spreading and prevent its sometimes devastating effects.”

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE